碧迪医疗(BDX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BDX 碧迪医疗

交易中 11-04 14:56:25 EST

233.88

-1.36

-0.58%

最高237.42	最低233.01	成交量101.92万
今开235.70	昨收235.24	日振幅1.87%
总市值676.00亿	流通市值674.54亿	总股本2.89亿
成交额2.39亿	换手率0.35%	流通股本2.88亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BDX","market":"US","secType":"STK","nameCN":"碧迪医疗","latestPrice":233.875,"timestamp":1730750185230,"preClose":235.24,"halted":0,"volume":1019241,"delay":0,"floatShares":288420051,"shares":289042418,"eps":4.844599,"marketStatus":"交易中","marketStatusCode":2,"change":-1.365,"latestTime":"11-04 14:56:25 EST","open":235.695,"high":237.42,"low":233.01,"amount":239169079.5381,"amplitude":0.018747,"askPrice":233.94,"askSize":304,"bidPrice":233.84,"bidSize":1,"shortable":3,"etf":0,"ttmEps":4.844599,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1730754000000},"adr":0,"listingDate":-240782400000,"adjPreClose":235.24,"adrRate":0,"dividendRate":0.016077,"preHourTrading":{"tag":"盘前","latestPrice":237.24,"preClose":235.24,"latestTime":"09:00 EST","volume":204,"amount":48101.22936,"timestamp":1730728803936},"postHourTrading":{"tag":"盘后","latestPrice":235.24,"preClose":235.24,"latestTime":"19:38 EDT","volume":120035,"amount":28237032.53,"timestamp":1730504285196},"volumeRatio":1.189863,"impliedVol":0.2883,"impliedVolPercentile":0.9641},"requestUrl":"/m/hq/s/BDX","defaultTab":"news","newsList":[{"id":"2470272441","title":"碧迪医疗雒剑：今年有一个战略性项目要落地河南","url":"https://stock-news.laohu8.com/highlight/detail?id=2470272441","media":"大河财立方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470272441?lang=zh_cn&edition=full","pubTime":"2024-09-26 14:26","pubTimestamp":1727331976,"startTime":"0","endTime":"0","summary":"【大河财立方记者王鑫】9月25日，以“投资河南跨享未来”为主题的2024河南与跨国公司合作交流会在郑州隆重举行。当天下午，作为大会系列活动之一，现代医药产业圆桌对接会吸引了众多医疗机构及跨国药企参与，与会者就医药产业相关议题展开讨论。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202409263191970974.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1059921491.USD","BK4585","BK4504","LU1571399168.USD","BK4588","IE00BFXG1179.USD","LU1854104046.USD","LU0289739343.SGD","BDX","BK4082","LU0266013472.USD","LU0289961442.SGD","LU1854103824.USD","LU0511384066.AUD"],"gpt_icon":0},{"id":"2458385516","title":"碧迪医疗2024财年第二财季实现净利润4.87亿美元，同比增加19.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458385516","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458385516?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:15","pubTimestamp":1723220117,"startTime":"0","endTime":"0","summary":"8月10日，碧迪医疗公布财报，公告显示公司2024财年第二财季净利润为4.87亿美元，同比增加19.66%；其中营业收入为49.90亿美元，同比增加2.30%，每股基本收益为1.68美元。从资产负债表来看，碧迪医疗总负债297.14亿美元，其中短期债务11.92亿美元，资产负债比为1.88，流动比率为1.85。机构评级：截至2024年8月10日，当前有14家机构对碧迪医疗目标价做出预测，其中目标均价为275.03美元，其中最低目标价为240.00美元，最高目标价为312.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100015209f1e0e94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100015209f1e0e94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDX"],"gpt_icon":0},{"id":"2456330484","title":"Becton Dickinson and Co 公布截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2456330484","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456330484?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:53","pubTimestamp":1722520413,"startTime":"0","endTime":"0","summary":"   * Becton Dickinson and Co   公布的截至1月份的季度调整后每股收益为3.50美元，高于去年同期的每股收益2.96美元。15 位分析师对该季度的平均预期为每股收益 3.31 美元。华尔街预期为每股收益 3.27 美元至 3.37 美元。* 营收为 50.6 亿美元，同比增长 3.7%；分析师预期为 50.8 亿美元。* 据报告，Becton Dickinson 公司本季度每股收益为 1.68 美元。* 公司报告的季度净收入为 4.87 亿美元。* 本季度 Becton Dickinson and Co 的股价上涨了 3.1%，今年到目前为止下跌了 1.1%。华尔街对 Becton Dickinson and Co 的 12 个月目标价中位数为 280.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","LU1854103824.USD","LU1571399168.USD","LU0289739343.SGD","BK4082","LU0511384066.AUD","BK4585","BDX","LU0266013472.USD","LU0289961442.SGD","IE00BFXG1179.USD","BDXA","BK4504","BK4588"],"gpt_icon":0},{"id":"1109586954","title":"异动解读 | 碧迪医疗第三季度收入不佳 下调全年利润预期 股价大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109586954","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109586954?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:38","pubTimestamp":1722519539,"startTime":"0","endTime":"0","summary":"医疗设备制造商碧迪医疗(BDX)周四盘中股价大跌5.03%,引发市场广泛关注。这主要是由于公司公布的第三季度财报数据不佳所致。\n\n碧迪医疗公布,第三季度营收为50.8亿美元,低于分析师平均预期。尽管公司每股收益3.50美元高于预期,但营收不佳仍令投资者失望。\n\n与此同时,碧迪医疗还下调了全年利润预期的下限,将其从每股12.95美元上调至13.05美元,上限13.15美元不变。这一调整也加剧了市场对公司前景的担忧,导致股价大幅下挫。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX"],"gpt_icon":0},{"id":"2456438992","title":"碧迪医疗盘中异动 早盘大幅下跌5.47%报227.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456438992","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456438992?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:31","pubTimestamp":1722519096,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时31分，碧迪医疗股票出现波动，股价大幅下跌5.47%。截至发稿，该股报227.89美元/股，成交量8.2408万股，换手率0.03%，振幅1.08%。碧迪医疗股票所在的医疗设备行业中，整体跌幅为0.48%。碧迪医疗公司简介：碧迪医疗是全球最大的医疗手术产品制造商和分销商。碧迪医疗业务占总业务量的近一半，碧迪生命科学业务和 碧迪介入业务占其余部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012131379f05afbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012131379f05afbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4504","BK4588","LU1854103824.USD","LU0266013472.USD","BDX","LU1854104046.USD","IE00BFXG1179.USD","LU1571399168.USD","LU0511384066.AUD","LU0289961442.SGD","BK4082","LU0289739343.SGD","BK4585"],"gpt_icon":0},{"id":"2456871574","title":"BUZZ-拜顿因第三季度收入不及预期而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2456871574","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456871574?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:11","pubTimestamp":1722517876,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月1日 - ** 医疗设备制造商 Becton Dickinson    股价盘前下跌 5.2% 至 228.61 美元** (link)，低于分析师平均预期的 50.8 亿美元。** 每股收益 3.50 美元，低于分析师平均预期的每股收益 3.31 美元 - LSEG 数据** 公司将全年副利润预测区间的下限从每股12.95美元上调至13.05美元，将上限维持在13.15美元不变。** 截至上次收盘，股价累计下跌 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739343.SGD","BK4585","BK4504","BK4588","BUZZ","LU1854103824.USD","LU0511384066.AUD","LU0266013472.USD","BK4082","IE00BFXG1179.USD","BDX","LU1854104046.USD","LU0289961442.SGD","LU1571399168.USD"],"gpt_icon":0},{"id":"2456489029","title":"药物输送设备需求旺盛，百通迪金森利润超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2456489029","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456489029?lang=zh_cn&edition=full","pubTime":"2024-08-01 20:24","pubTimestamp":1722515074,"startTime":"0","endTime":"0","summary":"    路透8月1日 - 拜克顿-迪金森公司  周四公布的第三季度 利润好于预期，这得益于对其给药设备的强劲需求。这家设备制造商曾表示，预计这项交易将立即增加其所有关键财务指标。这家总部位于新泽西州的集团将全年调整后利润预测区间的下限从 12.95 美元上调至 13.05 美元，上限维持在 13.15 美元不变。截至 6 月 30 日的第三季度，该公司调整后每股收益为 3.50 美元，高于分析师预计的每股 3.31 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU1989764664.SGD","SG9999002232.USD","LU0466842654.USD","LU1032466523.USD","BK4566","ABT","BK4550","LU0238689110.USD","LU1280957306.USD","LU1989763427.SGD","IE00BSNM7G36.USD","LU1585245621.USD","BK4082","LU1732799900.SGD","IE00BJT1NW94.SGD","LU2491050071.SGD","LU2506951958.HKD","LU1061106388.HKD","LU1854104046.USD","LU1732800096.USD","LU1989764748.USD","LU1989771016.USD","LU2324357040.USD","LU2362541273.HKD","LU0795875086.SGD","LU1057294990.SGD","BK4588","LU0950375773.USD","LU1430594728.SGD","BK4581","BSX","BK4504","IE00B4R5TH58.HKD","SG9999002224.SGD","BK4585","LU0912757837.SGD","LU1066053197.SGD","LU0170899867.USD","LU1989772840.SGD","LU1066051811.HKD","LU2491049909.HKD","BK4007","LU1023059063.AUD","LU1935042991.SGD","LU2087625088.SGD","LU2491050154.USD","LU1291159041.SGD","BDX"],"gpt_icon":1},{"id":"2455961027","title":"Becton Dickinson and Co   预计每股收益3.31美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455961027","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455961027?lang=zh_cn&edition=full","pubTime":"2024-07-31 02:36","pubTimestamp":1722364590,"startTime":"0","endTime":"0","summary":"   * Becton Dickinson and Co    预计将在8月1日公布截至2024年6月30日的季度收入报告。* 根据LSEG的数据，13位分析师的平均预期显示，这家总部位于新泽西富兰克林湖区的公司的营收预计将从去年同期的48.8亿美元增长4.1%，达到50.76亿美元。   * LSEG 的分析师平均预期 Becton Dickinson and Co 每股收益为 3.31 美元。* 华尔街对 Becton Dickinson and Co 的 12 个月目标价中位数为 280.00 美元，高于其上次收盘价 237.84 美元。7月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX","BDXA"],"gpt_icon":0},{"id":"2454851670","title":"BUZZ-爱德华生命科学公司第二季度营收不及预期，业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2454851670","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454851670?lang=zh_cn&edition=full","pubTime":"2024-07-25 05:54","pubTimestamp":1721858043,"startTime":"0","endTime":"0","summary":"    7月24日 - ** 医疗设备制造商爱德华生命科学公司股价在盘后交易中下跌超过16%，至72.7美元。** 受人工心脏瓣膜需求低于预期的影响，该公司第二季度营收不及预期** 营收为13.9亿美元，低于分析师预计的16.5亿美元--LSEG数据；每股收益为70美分，略高于预计的69美分。** EW 预测第三季度销售额在 15.6 亿美元至 16.4 亿美元之间，假定整个季度都包括其重症监护部门的收入，该部门已同意以 42 亿美元的价格出售给 Becton Dickinson    公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EW","BUZZ","BDX"],"gpt_icon":0},{"id":"2454515618","title":"由于心脏设备需求疲软，Edwards Lifesciences 第二季度营收不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2454515618","media":"Reuters","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454515618?lang=zh_cn&edition=full","pubTime":"2024-07-25 05:49","pubTimestamp":1721857785,"startTime":"0","endTime":"0","summary":"LSEG数据显示，爱德华兹公司第二季度营收为13.9亿美元，低于分析师预计 的16.5亿美元。另外，爱德华兹公司上个月将   ，将其重症监护产品部门 出售 给了Becton Dickinson   ，该公司表示将收购心脏设备制造商JenaValve Technology和Endotronix，以扩大其结构性心脏产品组合 。这些交易的价值约为12亿美元，进一步巩固了Edwards向纯粹的结构性心脏公司的转型，其主导产品是经导管主动脉瓣置换 设备，用于微创心脏手术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX","MDT","ABT","EW"],"gpt_icon":0},{"id":"2450187576","title":"花旗：维持Becton Dickinson(BDX.US)评级，由中性调整至中性评级, 目标价由260.00美元调整至255.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450187576","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450187576?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:00","pubTimestamp":1720659639,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4534","LU2417539215.USD","LU0320765646.SGD","LU0511384066.AUD","LU0128525689.USD","IE00BSNM7G36.USD","LU1791807156.HKD","LU2236285917.USD","BK4082","LU0106831901.USD","LU0130517989.USD","LU0162691827.USD","LU0289739343.SGD","LU1162221912.USD","LU1201861249.SGD","LU1854104046.USD","LU2462157665.USD","LU0289961442.SGD","LU0477156953.USD","BK4207","LU1668664300.SGD","BK4504","LU1854103824.USD","BK4588","LU0266013472.USD","LU0052756011.USD","LU0072461881.USD","LU0310800965.SGD","LU0130102774.USD","LU1366192091.USD","BDX","LU0098860793.USD","IE00BFXG1179.USD","BK4566","LU0648001328.SGD","LU1267930227.SGD","LU1571399168.USD","LU0980610538.SGD","LU2456880835.USD"],"gpt_icon":0},{"id":"2450848267","title":"美国食品和药物管理局示意百通狄金森公司血液试管短缺","url":"https://stock-news.laohu8.com/highlight/detail?id=2450848267","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450848267?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:49","pubTimestamp":1720630166,"startTime":"0","endTime":"0","summary":"    路透7月10日 - 美国食品和药物管理局周三向实验室和医疗服务提供商发出警告，称用于诊断细菌和真菌感染的Becton Dickinson  血液试管出现短缺。背景上个月，Becton 公司向  发函警告，由于供应商塑料瓶供应量减少，未来几个月 BACTEC 血液培养基供应可能会出现延误。Becton 公司表示正在采取措施解决这一问题，包括使用空运和修改生产计划以实现快速生产。数字美国疾病控制与预防中心称，美国每年至少有 170 万成年人患败血症，近 27 万人因此死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","LU1854103824.USD","LU1571399168.USD","LU0289739343.SGD","BK4082","LU0511384066.AUD","BK4585","BDX","LU0266013472.USD","LU0289961442.SGD","IE00BFXG1179.USD","BK4504","BK4588"],"gpt_icon":0},{"id":"2441051879","title":"碧迪医疗举债232亿元加码重症监护，能否扭转业绩下滑颓势？","url":"https://stock-news.laohu8.com/highlight/detail?id=2441051879","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441051879?lang=zh_cn&edition=full","pubTime":"2024-06-07 18:52","pubTimestamp":1717757573,"startTime":"0","endTime":"0","summary":"为了筹集收购资金，碧迪医疗计划动用约10亿美元的现金，以及32亿美元的新债务，这一债务折合人民币约232亿元。碧迪医疗举债收购的首要原因或许为业绩压力，其净利润在近两年半内连续下滑。期间碧迪医疗实现净利润14.84亿美元，同比下降16.6%；2022年实现净利润17.79亿美元，同比下降14.96%。本次集采中，碧迪医疗的留置针中标价格包括4.8元、4.2元、13.99元等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406071856149f241618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406071856149f241618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0289739343.SGD","BK4504","LU1854103824.USD","LU1854104046.USD","LU0266013472.USD","BK4082","LU0289961442.SGD","LU0511384066.AUD","LU1571399168.USD","BDX","BK4585","BK4588"],"gpt_icon":0},{"id":"2441264367","title":"爱德华生命科学作价42亿美元向碧迪医疗出售重症监护业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2441264367","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441264367?lang=zh_cn&edition=full","pubTime":"2024-06-05 06:57","pubTimestamp":1717541832,"startTime":"0","endTime":"0","summary":"爱德华生命科学（Edwards Lifesciences）近日宣布与碧迪医疗（Becton, Dickinson and Company）达成最终协议，将旗下重症监护全线产品以42亿美元现金方式出售给碧迪医疗。基于此项协议，爱德华不再继续推进此前宣布的重症监护业务分拆计划。该交易预计将在2024年底前完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605065712af8bf51f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605065712af8bf51f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4504","LU1854103824.USD","LU1854104046.USD","LU0266013472.USD","BDX","BK4588","LU0289961442.SGD","LU1571399168.USD","BK4585","LU0289739343.SGD","LU0511384066.AUD"],"gpt_icon":0},{"id":"2440223289","title":"爱德华生命科学公司当地时间6月3日宣布计划以42亿美元的全现金交易将其重症监护产品部门出售给碧迪医疗（Becton Dickinson）从而进一步加强对结构心脏设备业务的关注。","url":"https://stock-news.laohu8.com/highlight/detail?id=2440223289","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440223289?lang=zh_cn&edition=full","pubTime":"2024-06-04 23:18","pubTimestamp":1717514322,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1854103824.USD","LU1854104046.USD","BK4504","BK4082","LU0266013472.USD","BDX","LU0289739343.SGD","BK4585","LU0289961442.SGD","LU1571399168.USD","BK4588","LU0511384066.AUD"],"gpt_icon":0},{"id":"2440741306","title":"碧迪医疗(BDX)涨逾2.6% 将以42亿美元现金收购爱德华生命科学(EW)重症监护产品组","url":"https://stock-news.laohu8.com/highlight/detail?id=2440741306","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440741306?lang=zh_cn&edition=full","pubTime":"2024-06-04 01:28","pubTimestamp":1717435701,"startTime":"0","endTime":"0","summary":"金吾财讯 | 碧迪医疗(BDX)股价震荡走高，高见241.635美元，涨近4%，截至发稿，仍涨2.67%，报238.17美元，成交额2.41亿美元。日前，碧迪医疗(BDX)和爱德华生命科学(EW)宣布了一项最终协议，根据该协议，碧迪医疗将以42亿美元现金收购Edwards重症监护产品组，后者是先进监测解决方案的全球领导者，从而释放新的价值创造机会并增强比对医疗的智能互联护理解决方案组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604012836958a8ced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604012836958a8ced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EW","BK4585","BK4588","LU1854103824.USD","BDX","LU0511384066.AUD","LU0289961442.SGD","BK4567","BK4504","LU0266013472.USD","LU1571399168.USD","LU1854104046.USD","BK4082","LU0289739343.SGD"],"gpt_icon":0},{"id":"2440528462","title":"碧迪医疗(BDX.US)42亿美元巨资收购爱德华生命科学(EW.US)重症监护部门 盘前涨超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440528462","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440528462?lang=zh_cn&edition=full","pubTime":"2024-06-03 20:00","pubTimestamp":1717416019,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，碧迪医疗宣布，已同意以42亿美元现金收购爱德华生命科学的重症监护部门，此举旨在拓展其医疗监测产品线。此外，自2015年起担任爱德华生命科学重症监护部门副总裁的Katie Szyman，将负责领导碧迪医疗的重症监护业务。据了解，爱德华生命科学重症监护部门的产品线包括Swan Ganz肺动脉导管、微创传感器、组织血氧仪传感器以及监视器等。截至发稿，碧迪医疗盘前涨1.45%，报235.33美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1130341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0511384066.AUD","BK4082","LU0289739343.SGD","LU1854103824.USD","BK4504","BK4588","LU1854104046.USD","BK4585","LU0266013472.USD","BDX","LU0289961442.SGD","EW","LU1571399168.USD","BK4567"],"gpt_icon":0},{"id":"2440846654","title":"BUZZ-Edwards Lifesciences 上涨；将以 42 亿美元出售重症监护部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2440846654","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440846654?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:57","pubTimestamp":1717412248,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    6月3日 - ** 医疗设备制造商爱德华生命科学公司  股价盘前上涨3.4%至89.80美元 ** 称已同意 (link) 将其重症监护产品部门出售给 Becton Dickinson   ，全现金交易价值 42 亿美元。** 根据这项协议，公司将不再继续推进此前宣布的分拆重症监护产品部门的计划 - EW ** 预计交易将于 2024 年底完成** BDX 表示，预计将以约 10 亿美元现金和 32 亿美元新债为交易提供资金** 截至上次收盘，EW年累计上涨13.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EW","BK4567","LU0266013472.USD","LU0289961442.SGD","BUZZ","LU1854104046.USD","BK4082","LU0289739343.SGD","BDX","LU0511384066.AUD","BK4585","BK4588","LU1571399168.USD","BK4504","LU1854103824.USD"],"gpt_icon":0},{"id":"2440652814","title":"更新版 1-爱德华生命科学公司将以 42 亿美元的价格向 Becton Dickinson 公司出售关键产品部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2440652814","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440652814?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:50","pubTimestamp":1717411852,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (添加详细信息)    路透6月3日 - 爱德华生命科学公司  周一表示，已同意将其重症监护产品部门出售给Becton Dickinson 公司  ，全现金交易价值42亿美元。 根据这项协议，总部位于加利福尼亚州的爱德华兹公司表示，它不再寻求分拆之前宣布的重症监护产品部门。  这家医疗设备制造商曾 在 4 月 (link) ，表示将在 2024 年底分拆重症监护部门，集中精力发展更大的心脏设备业务。     在满足或放弃某些成交条件的前提下，该交易预计将于2024年底完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4567","EW","LU0289739343.SGD","LU1854103824.USD","BK4588","LU1854104046.USD","LU0511384066.AUD","BK4082","LU0289961442.SGD","LU1571399168.USD","LU0266013472.USD","BDX","BK4585"],"gpt_icon":0},{"id":"2440146557","title":"爱德华生命科学公司将以 42 亿美元的价格向 Becton Dickinson 公司出售其关键产品部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2440146557","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440146557?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:37","pubTimestamp":1717411056,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月3日 - 爱德华生命科学公司（Edwards Lifesciences   ）周一表示，该公司已同意将其重症监护产品部门出售给Becton, Dickinson and Co   公司，该交易为全现金交易，价值42亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","LU0289961442.SGD","BK4567","EW","BDX","LU0289739343.SGD","BK4504","BK4082","BK4585","LU1854103824.USD","LU0511384066.AUD","LU1854104046.USD","BK4588","LU1571399168.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bd.com","stockEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.0189},{"period":"3month","weight":-0.0274},{"period":"6month","weight":0.0024},{"period":"1year","weight":-0.0808},{"period":"ytd","weight":-0.0352}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"碧迪医疗器械有限公司于1906年11月根据新泽西州法律注册成立。该公司是一家全球性的医疗技术公司，从事医疗机构、医生、生命科学研究人员、临床实验室、制药行业和公众使用的各种医疗用品、设备、实验室设备和诊断产品的开发、制造和销售。公司提供客户解决方案，重点是改善药物管理和患者安全；支持感染预防实践；配备手术和介入手术；改进药物输送；协助麻醉护理；加强传染病和癌症的诊断；促进细胞研究和应用；支持糖尿病的管理。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.038615},{"month":2,"riseRate":0.5,"avgChangeRate":0.004773},{"month":3,"riseRate":0.568182,"avgChangeRate":-0.003408},{"month":4,"riseRate":0.511111,"avgChangeRate":0.007201},{"month":5,"riseRate":0.488889,"avgChangeRate":0.013555},{"month":6,"riseRate":0.622222,"avgChangeRate":0.006927},{"month":7,"riseRate":0.577778,"avgChangeRate":-0.000947},{"month":8,"riseRate":0.644444,"avgChangeRate":0.00845},{"month":9,"riseRate":0.377778,"avgChangeRate":-0.001917},{"month":10,"riseRate":0.488889,"avgChangeRate":0.006834},{"month":11,"riseRate":0.666667,"avgChangeRate":0.022002},{"month":12,"riseRate":0.681818,"avgChangeRate":0.02022}],"exchange":"NYSE","name":"碧迪医疗","nameEN":"Becton Dickinson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"碧迪医疗(BDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供碧迪医疗(BDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"碧迪医疗,BDX,碧迪医疗股票,碧迪医疗股票老虎,碧迪医疗股票老虎国际,碧迪医疗行情,碧迪医疗股票行情,碧迪医疗股价,碧迪医疗股市,碧迪医疗股票价格,碧迪医疗股票交易,碧迪医疗股票购买,碧迪医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"碧迪医疗(BDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供碧迪医疗(BDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}